109 related articles for article (PubMed ID: 10342323)
21. T-cell receptor beta-chain usage in directly activated alloreactive CD4+ T cells: unrestricted Vbeta gene usage with CDR3 size limitations.
Zhai Y; Kupiec-Weglinski JW
Transplantation; 2003 Feb; 75(4):514-21. PubMed ID: 12605120
[TBL] [Abstract][Full Text] [Related]
22. Role of CD4+ and CD8+ T cells in allorecognition: lessons from corneal transplantation.
Boisgérault F; Liu Y; Anosova N; Ehrlich E; Dana MR; Benichou G
J Immunol; 2001 Aug; 167(4):1891-9. PubMed ID: 11489968
[TBL] [Abstract][Full Text] [Related]
23. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo.
Hara M; Kingsley CI; Niimi M; Read S; Turvey SE; Bushell AR; Morris PJ; Powrie F; Wood KJ
J Immunol; 2001 Mar; 166(6):3789-96. PubMed ID: 11238621
[TBL] [Abstract][Full Text] [Related]
24. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses.
Kingsley CI; Karim M; Bushell AR; Wood KJ
J Immunol; 2002 Feb; 168(3):1080-6. PubMed ID: 11801641
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of tolerance induction after intrathymic islet injection: determination of the fate of alloreactive thymocytes.
Turvey SE; Hara M; Morris PJ; Wood KJ
Transplantation; 1999 Jul; 68(1):30-9. PubMed ID: 10428263
[TBL] [Abstract][Full Text] [Related]
26. Cytotoxic T lymphocyte precursor cells specific for the major histocompatibility complex class I-like antigen, Qa-2, require CD4+ T cells to become primed in vivo and to differentiate into effector cells in vitro.
Muraoka S
Eur J Immunol; 1991 Sep; 21(9):2095-103. PubMed ID: 1679712
[TBL] [Abstract][Full Text] [Related]
27. Long-term cardiac allograft survival across an MHC mismatch after "pruning" of alloreactive CD4 T cells.
Hu M; Watson D; Zhang GY; Graf N; Wang YM; Sartor M; Howden B; Fletcher J; Alexander SI
J Immunol; 2008 May; 180(10):6593-603. PubMed ID: 18453578
[TBL] [Abstract][Full Text] [Related]
28. Analysis of the CD40 and CD28 pathways on alloimmune responses by CD4+ T cells in vivo.
Bingaman AW; Ha J; Durham MM; Waitze SY; Tucker-Burden C; Cowan SR; Pearson TC; Larsen CP
Transplantation; 2001 Oct; 72(7):1286-92. PubMed ID: 11602857
[TBL] [Abstract][Full Text] [Related]
29. Homing of in vitro-generated donor antigen-reactive CD4+ T lymphocytes to renal allografts is alpha 4 beta 1 but not alpha L beta 2 integrin dependent.
Hammer MH; Zhai Y; Katori M; Ritter T; Volk HD; Coito AJ; Kupiec-Weglinski JW
J Immunol; 2001 Jan; 166(1):596-601. PubMed ID: 11123342
[TBL] [Abstract][Full Text] [Related]
30. Clonal competition inhibits the proliferation and differentiation of adoptively transferred TCR transgenic CD4 T cells in response to infection.
Foulds KE; Shen H
J Immunol; 2006 Mar; 176(5):3037-43. PubMed ID: 16493062
[TBL] [Abstract][Full Text] [Related]
31. Memory T-cell predominance following T-cell depletional therapy derives from homeostatic expansion of naive T cells.
Sener A; Tang AL; Farber DL
Am J Transplant; 2009 Nov; 9(11):2615-23. PubMed ID: 19775313
[TBL] [Abstract][Full Text] [Related]
32. Rapamycin or tacrolimus alone fails to resist cardiac allograft accelerated rejection mediated by alloreactive CD4(+) memory T cells in mice.
Liang H; Liao C; Qi Z; Sha C; Xie B; Chen J; Xia J; Wang Y; Yao Q; Zhao Y
Transpl Immunol; 2010 Feb; 22(3-4):128-36. PubMed ID: 19755159
[TBL] [Abstract][Full Text] [Related]
33. Alloantigen affinity and CD4 help determine severity of graft-versus-host disease mediated by CD8 donor T cells.
Yu XZ; Albert MH; Anasetti C
J Immunol; 2006 Mar; 176(6):3383-90. PubMed ID: 16517706
[TBL] [Abstract][Full Text] [Related]
34. Rapamycin does not induce anergy but inhibits expansion and differentiation of alloreactive human T cells.
Nikolaeva N; Bemelman FJ; Yong SL; van Lier RA; ten Berge IJ
Transplantation; 2006 Feb; 81(3):445-54. PubMed ID: 16477233
[TBL] [Abstract][Full Text] [Related]
35. Progressive changes in CD45RB phenotype and lymphokine production by murine CD4+ T cells after alloantigen exposure.
Birkeland ML; Kraus T; Tardelli L; Puré E
Immunology; 1992 Apr; 75(4):632-8. PubMed ID: 1350569
[TBL] [Abstract][Full Text] [Related]
36. Helper T lymphocyte unresponsiveness to cardiac allografts following transient depletion of CD4-positive cells. Implications for cellular and humoral responses.
Bishop DK; Li W; Chan SY; Ensley RD; Shelby J; Eichwald EJ
Transplantation; 1994 Sep; 58(5):576-84. PubMed ID: 7522364
[TBL] [Abstract][Full Text] [Related]
37. Antigen-dependent suppression of alloresponses by Foxp3-induced regulatory T cells in transplantation.
Albert MH; Liu Y; Anasetti C; Yu XZ
Eur J Immunol; 2005 Sep; 35(9):2598-607. PubMed ID: 16078276
[TBL] [Abstract][Full Text] [Related]
38. Selective depletion of alloreactive T cells leads to long-term islet allograft survival across a major histocompatibility complex mismatch in diabetic mice.
Hu M; Wu J; Zhang GY; Wang YM; Watson D; Yi S; Hawthorne WJ; O'Connell PJ; Alexander SI
Cell Transplant; 2013; 22(10):1929-41. PubMed ID: 23107388
[TBL] [Abstract][Full Text] [Related]
39. Lack of cognate help by CD4+ T cells and anergy of CD8+ T cells are the principal mechanisms for anti-leukocyte function-associated antigen-1/intercellular adhesion molecule-1-induced cardiac allograft tolerance.
Bashuda H; Seino K; Ra C; Yagita H; Okumura K
Transplantation; 1997 Jan; 63(1):113-8. PubMed ID: 9000671
[TBL] [Abstract][Full Text] [Related]
40. CD4+CD25+ regulatory T cells do not significantly contribute to direct pathway hyporesponsiveness in stable renal transplant patients.
Game DS; Hernandez-Fuentes MP; Chaudhry AN; Lechler RI
J Am Soc Nephrol; 2003 Jun; 14(6):1652-61. PubMed ID: 12761268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
